Trip or No Trip? The Diverging Development of Psychedelic Drugs for Mental Health (Subscription required) Adrienne Rivlin Read more
Executive Insights Life Sciences & Pharma Is Biopharma Doing Enough to Advance Novel Targets? May 15, 2025
Executive Insights Life Sciences & Pharma Advanced In Vitro Models: Opportunities and Challenges for US Drug Development May 7, 2025
Executive Insights Life Sciences & Pharma Radiotherapeutics on the Rise: Addressing Supply Chain Complexity April 7, 2025
Executive Insights Life Sciences & Pharma Redefining Biopharma R&D Productivity: New Insights and Strategies January 9, 2025